Lexicon Pharmaceuticals Reports First Quarter 2019 Financial Results and Provides a Business Update

Go back to Lexicon Pharmaceuticals Reports First Quarter 2019 Financial Results and Provides a Business Update

Lexicon Pharma (LXRX) Tops Q1 EPS by 1c

May 1, 2019 7:23 AM EDT

Lexicon Pharma (NASDAQ: LXRX) reported Q1 EPS of ($0.21), $0.01 better than the analyst estimate of ($0.22). Revenue for the quarter came in at $9.22 million versus the consensus estimate of $13.27 million.

For earnings history and earnings-related data on Lexicon Pharma (LXRX) click here.

... More